Svennilson Peter's Form 4 filing
Tenaya Therapeutics, Inc. (TNYA) · filed Feb 12, 2026
- Accession no.
- 0001193125-26-049028
- Filed
- Feb 12, 2026, 5:19 PM ET
- Trade date
- Feb 10-11, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Svennilson PeterCIK 0001606074 | 10% Owner |
| Kutzkey TimCIK 0001614186 | 10% Owner |
| Column Group III-A, LPCIK 0001668085 | 10% Owner |
| Column Group III, LPCIK 0001668159 | 10% Owner |
| Column Group III GP, LPCIK 0001790965 | 10% Owner |
| Column Group Opportunity III, LPCIK 0001931825 | 10% Owner |
| TCG Opportunity III GP, LLCCIK 0001932445 | 10% Owner |
| Column Group Opportunity III GP, LPCIK 0001932874 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Common Stock | SSaleDisposed | −161,422 | $0.8161 | −$131,736.49 | 4,253,298 | Indirect | |
| Feb 10, 2026 | Common Stock | SSaleDisposed | −182,295 | $0.8161 | −$148,770.95 | 4,803,275 | Indirect | |
| Feb 11, 2026 | Common Stock | SSaleDisposed | −1,905,115 | $0.6808 | −$1,297,002.29 | 2,348,183 | Indirect | |
| Feb 11, 2026 | Common Stock | SSaleDisposed | −2,151,458 | $0.6808 | −$1,464,712.61 | 2,651,817 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.